Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-10-09
DOI
10.1093/infdis/jiz517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy
- (2018) Rokeya Sultana Rekha et al. BMC INFECTIOUS DISEASES
- The Pleiotropic Effects of Statins – From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia
- (2018) James K. Liao et al. Current Vascular Pharmacology
- Remembering the Host in Tuberculosis Drug Development
- (2018) Daniel J Frank et al. JOURNAL OF INFECTIOUS DISEASES
- Statin Adjunctive Therapy for Tuberculosis Treatment
- (2016) Jan-Willem C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is There Potential for Repurposing Statins as Novel Antimicrobials?
- (2016) Emma Hennessy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence againstMycobacterium tuberculosisin human and murine cells
- (2016) Ekta Lachmandas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Statin adjunctive therapy shortens the duration of TB treatment in mice
- (2016) Noton K. Dutta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort
- (2016) Chih-Cheng Lai et al. THORAX
- Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
- (2016) Selvakumar Subbian et al. EBioMedicine
- Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
- (2015) Michael B. Harbut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of a Novel Necrotic Granuloma Model of Latent Tuberculosis Infection and Reactivation in Mice
- (2014) Noton K. Dutta et al. AMERICAN JOURNAL OF PATHOLOGY
- Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis
- (2014) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Statins Increase Rifampin Mycobactericidal Effect
- (2014) Lívia Silva Lobato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium lepraeintracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment
- (2014) Katherine A. Mattos et al. CELLULAR MICROBIOLOGY
- Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
- (2014) G. E. Velasquez et al. CLINICAL INFECTIOUS DISEASES
- PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice
- (2014) Noton K. Dutta et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
- (2014) C. Skerry et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cutting Edge: Vitamin D Regulates Lipid Metabolism in Mycobacterium tuberculosis Infection
- (2014) H. Salamon et al. JOURNAL OF IMMUNOLOGY
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
- (2013) Suraj P. Parihar et al. JOURNAL OF INFECTIOUS DISEASES
- Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
- (2013) T. R. Hawn et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function
- (2013) Anna Sokolovska et al. NATURE IMMUNOLOGY
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Infection of macrophages withMycobacterium tuberculosisinduces global modifications to phagosomal function
- (2012) Maria Podinovskaia et al. CELLULAR MICROBIOLOGY
- Tuberculosis chemotherapy : Present situation, possible solutions, and progress towards a TB-free world
- (2012) PetrosC Karakousis et al. Indian Journal of Medical Microbiology
- Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence
- (2011) N. Andreu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis
- (2011) Stephen D Lawn et al. LANCET
- Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view
- (2009) Carleitta Paige et al. CELLULAR MICROBIOLOGY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Statins limit Rickettsia conorii infection in cells
- (2008) E. Botelho-Nevers et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Lovastatin, but not pravastatin, limits in vitro infection due to Coxiella burnetii
- (2008) E. Botelho-Nevers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Host-Directed Drug Targeting of Factors Hijacked by Pathogens
- (2008) A. Schwegmann et al. Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started